Skip to main content

Advertisement

Log in

Public health and carrageenan regulation: a review and analysis

  • Published:
Journal of Applied Phycology Aims and scope Submit manuscript

Abstract

The status of carrageenan in the regulatory sphere influences how and where it may be used, with implications for seaweed farmers, carrageenan manufacturers and consumers. Over the period 1935 to the present the status of carrageenan has been effected by changes in the regulatory environment that reflect new understandings about carrageenan, health and health risks as well as broader trade, social and political changes. This paper reviews regulatory progress from the 1930s to the present. It reflects, in particular, the shifting priorities in public health and their effects on the regulatory status of carrageenan. Four case studies of public controversies about carrageenan safety are discussed in relation to regulatory responses and their public health significance. It is concluded that current assessments of risk associated with carrageenan have, in some contexts, failed to take into account the full spectrum of safety assessments that have been carried out and the maturing of food additive regulations thereby allowing a myth of risk to continue.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Abramsson-Zetterberg L, Svensson K (2005) Semicarbazide is not genotoxic in the flow cytometry-based micronucleus assay in vivo. Toxicol Lett 155:211–217

    Article  PubMed  CAS  Google Scholar 

  • AFC Panel (2005) Opinion of the scientific panel on food additives, flavourings, processing aids and materials in contact with foodon a request from the commission related to semicarbazide in food. EFSA J 219:1–36

    Google Scholar 

  • Ames BN, Gold LS (1997) Environmental pollution, pesticides, and the prevention of cancer: misconceptions [published erratum appears in FASEB J 1997 Dec;11(14):1330]. FASEB J 11:1041–1052

    PubMed  CAS  Google Scholar 

  • Ames BN, Gold LS (1998) The causes and prevention of cancer: The role of environment. Biotherapy 11:205–220

    Article  PubMed  CAS  Google Scholar 

  • Anderson W, Hargreaves GC (1965) Gastro-intestinal therapeutic. US Patent 3175942, March 13 1965

  • Atkins PJ, Bowler IR (2000) Food in society: economy, culture, geography. Arnold, London

    Google Scholar 

  • Bixler HJ (1994) The carrageenan connection IV. Br Food J 96:12–17

    Article  Google Scholar 

  • Bixler HJ (1996) Recent developments in manufacturing and marketing carrageenan. Hydrobiologia 326/327:35–57

    Article  CAS  Google Scholar 

  • Borthakur A, Bhattacharyya S, Dudeja PK, Tobacman JK (2007) Carrageenan induces interleukin-8 production through distinct Bcl10 pathway in normal human colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 292:G829–G838

    Article  PubMed  CAS  Google Scholar 

  • Buck CB, Thompson CD, Roberts JN, Müller M, Lowy DR, et al. (2006) Carrageenan is a potent inhibitor of Papillomavirus infection. PLoS Pathog 2(7): e69 doi:10.1371/journal.ppat.0020069

  • Carthew P (2002) Safety of carrageenan in foods. Environ Health Perspect 110:A176

    PubMed  Google Scholar 

  • Chapman VJ (1950) Seaweeds and their uses. 1st ed. Camelot Press, London

    Google Scholar 

  • Chapman J.(2001) Cancer food scare. Daily Mail October 27;Sect. V2:21

  • Chopin T (1998) The seaweed resources of Eastern Canada. In: Critchley AT, Ohno M (eds.) Seaweed resources of the world. Japan International Cooperation Agency, Yokosuka, Japan, pp 273–302

    Google Scholar 

  • Cohen S, Ito N (2002) A critical review of the toxicological effects of carrageenan and processed Eucheuma seaweed on the gastrointestinal tract. Crit Rev Toxicol 32:413–444

    Article  PubMed  CAS  Google Scholar 

  • Commission Directive (1995) Directive No. 95/2/EC and 96/85EC. Office for Official Publications of the European Communities [serial online]. Available via: http://europa.eu.int/eur-lex/en/consleg/pdf/1995/en_1995L0002_do_001.pdf

  • Council of the Pharmaceutical Society of Great Britain (1911) The British Pharmaceutical Codex. The Pharmaceutical Press, London

    Google Scholar 

  • Coveney J (2003) Why food policy is critical to public health. Crit Public Health 13:99–105

    Article  Google Scholar 

  • de la Calle MB, Anklam E (2005) Semicarbazide: occurrence in food products and state-of-the-art in analytical methods used for its determination. Analytical and Bioanalytical Chemistry 382:968–977

    Article  PubMed  CAS  Google Scholar 

  • Dean R (1989) Food additives: their regulatory status. In: Lewis RJ (ed.) Food additives handbook. Van Nostrand Reinhold, New York, pp 3–27

    Google Scholar 

  • European Commission (1992) Opinion of the scientific committee on food on carrageenan. Brussels: Health and Consumer Protection Directorate General. (SCF/CS/ADD/EMU/199 Final)

  • European Food Safety Authority (2003) Press Release: EFSA gives update on semicarbazide: No reason to change current dietary habits including for babies. Precautionary action by industry recommended for baby foods. Available via: http://www.efsa.europa.eu/etc/medialib/efsa/press_room/press_release/30.Par.0001.File.dat/15-10-2003_en1.pdf cited

  • European Parliament and Council (1995) Directive No. 95/2/EC and 96/85EC. Office for Official Publications of the European Communities

  • Felter HW, Lloyd JU (1898) King’s American dispensatory. Ohio Valley Co., Cincinnatti

    Google Scholar 

  • Fernandez-Romero JA, Thorn M, Turville SG, Titchen K, Sudol K, Li J et al. (2007) Carrageenan/MIV-150 (PC-815), a Combination Microbicide. Sex Transm Dis 34:9–14

    Article  PubMed  CAS  Google Scholar 

  • Food and Drug Administration (1958) Federal food, drug, and cosmetic act: Chapter II - Definitions. Sec. 201. [321]

  • Food and Drug Administration.(2004) Code of Federal Regulations: CFR Title 21 Database. Available via: http://www.fda.gov/ohrms/dockets/dockets/03n0338/03n-0338-tr00003.htm cited September 8 2004

  • Food and Drug Administration (2006) Part 172 - food additives permitted for direct addition to food for human consumption. Code of Federal Regulations, USA

    Google Scholar 

  • Garrett ES, Jahncke ML, Cole EA (1998) Effects of Codex and GATT. Food Control 9:177–182

    Article  Google Scholar 

  • Greig JB (1999) Carrageenan. Geneva. World Health Organisation: WHO safety evaluation of certain food additives. (Food Additive Series 42)

  • Hoenicke K, Gatermann R (2006) How can zero tolerances be controlled? The case study of Nitrofurans. Accreditation and quality assurance. J Qual Comparabili Reliabil Chem Meas 11:29–32

    CAS  Google Scholar 

  • Hoenicke K, Gatermann R, Hartig L, Mandix M, Otte S (2004) Formation of semicarbazide (SEM) in food by hypochlorite treatment: is SEM a specific marker for nitrofurazone abuse? Food Additives & Contaminants 21:526–537

    Article  CAS  Google Scholar 

  • Informatics Inc (1972) Monograph on carrageenan. Maryland: Submitted under contract to the Food and Drug Administration

  • JECFA (1974) Seventeenth report of the joint FAO/WHO Expert committee on food additives, WHO Technical Series, No. 539

  • JECFA (2001) Evaluation of certain food additives specifications. Addendum 9. Joint FAO/WHO expert committee on food additives, WHO Technical Report series, No.891

    Google Scholar 

  • Lang T (1999) The complexities of globalization: The UK as a case study of tensions within the food system and the challenge to food policy. Agric Human Values 16:169–185

    Article  Google Scholar 

  • Lewis JG, Stanley NF, Guist GG (1988) Commercial production and application of algal hydrocolloids. In: Lembi CA, Waaland JR (eds.) Algae and human affairs. Cambridge University Press, Cambridge, pp 205–236

    Google Scholar 

  • Livermore MA (2006) Authority and legitimacy in global governance: Deliberation, institutional differentiation, and the codex alimentarius. New York University Law Review 81(2):766–801

  • London Food Commission (1988) Food adulteration and how to beat it. Unwin, London

    Google Scholar 

  • Marcus AJ, Watt J (1969) Ulcerative colitis in the guinea-pig caused by seaweed extract. J Pharmaceut Pharmacol 21:187

    Google Scholar 

  • Marinalg International (2003) Position statement on carrageenan and semicarbazide: EC alert notification 2003/201. Available via: http://www.marinalg.org/papers/c_papers.htm cited April 15 2007

  • McHugh DJ (2003) A guide to the seaweed industry. Rome: FAO Fisheries Technical Paper No. 441

  • Merrill RA (1997) Food safety regulation: reforming the Delaney Clause. Annu Rev Public Health 18:313–340

    Article  PubMed  CAS  Google Scholar 

  • Millstone E, Van Zwanenberg P (2002) The evolution of food safety policy-making institutions in the UK, EU and Codex Alimentarius. Soc Policy Adm 36:593–609

    Article  Google Scholar 

  • Murphy E (2004) Risk, maternal ideologies and infant feeding. In: Williams L, Germov J (eds.) The social appetite: an introduction to the sociology of food and nutrition. Oxford University Press, Melbourne, pp 200–219

    Google Scholar 

  • Noah L (1999) Legal aspects of the food additive approval process, in enhancing the regulatory decision-making approval process for direct food ingredient technologies: workshop summary. Institute of Medicine (IOM), Washington DC

    Google Scholar 

  • Noah L, Merrill RA (1998) Starting from scratch? Reinventing the food additive approval process. Boston University Law Review 78:329–443

    Google Scholar 

  • Piper D, Fenton B (1961) Effect of a sulfated polysaccharide on peptic digestion. A study in vitro of carrageenin (Ebimar). Gastroenterology 40:638–643

    PubMed  CAS  Google Scholar 

  • Population Council (2006) Microbicide Program. Available via: http://www.popcouncil.org/microbicides/index.html cited 15 September 2006

  • Scientific Committee on Food (2003a) Opinion of the Scientific Committee on Food on carrageenan. Brussels: European Commission; 5 March. (SCF/CS/ADD/EMU/199 Final)

  • Scientific Committee on Food (2003b) Report of the scientific committee on food on the revision of essential requirements of infant formulae and follow-on formulae. European Union.

  • Shah ZC, Huffman FG (2003) Current availability and consumption of carrageenan-containing foods. Ecol Food Nutr 42:357–371

    Article  Google Scholar 

  • Smit AJ (2004) Medicinal and pharmaceutical uses of seaweed natural products: A review. J Appl Phycol 16:245–262

    Article  CAS  Google Scholar 

  • Stanley N (1987) Production, properties and uses of carrageenan. In: McHugh DJ (ed.) Production and utilization of products from commercial seaweeds, vol 288. FAO, Rome

    Google Scholar 

  • Tobacman JK (1998) (Effects of lambda-carrageenan on human mammary myoepithelial cells and relation to mammary carcinogenesis). In: International symposium on the impact of biotechnology on prediction, prevention and treatment of cancer. Nice, France

  • Tobacman JK (2001) Review of harmful gastrointestinal effects of carrageenan in animal experiments. Environ Health Perspect 109:983–994

    Article  PubMed  CAS  Google Scholar 

  • Tobacman JK, Wallace RB, Zimmerman MB (2001a) Consumption of carrageenan and other water-soluble polymers used as food additives and incidence of mammary carcinoma. Med Hypotheses 56:589–598

    Article  CAS  Google Scholar 

  • Tobacman JK, Walters KS (2001b) Carrageenan-induced inclusions in mammary myoepithelial cells. Cancer Detec Prev 25:520–526

    PubMed  CAS  Google Scholar 

  • Tomarelli RM, Tucker Jr WD, Bauman LM, Savini S, Weaber JR (1974) Nutritional quality of processed milk containing carrageenan. J Agric Food Chem 22:819–824

    Article  PubMed  CAS  Google Scholar 

  • Veggeland F, Borgen SB (2005) Negotiating international food standards: The World Trade Organization’s impact on the Codex Alimentarius commission. Governance 18:675–708

    Article  Google Scholar 

  • Vogel D (2001) Ships passing in the night: The changing politics of risk regulation in Europe and the United States RSCAS working papers: EUI RSC 2001/16

  • Weiner ML, Nuber D, Blakemore WR, Harriman JF, Cohen SM (2007) A 90-day dietary study on kappa carrageenan with emphasis on the gastrointestinal tract. Food Chem Toxicol 45:98–106

    Article  PubMed  CAS  Google Scholar 

  • Weisburger JH (1994) Does the delaney clause of the U.S. food and drug laws prevent human cancers? Toxicol Sci 22:483–493

    Article  CAS  Google Scholar 

  • Wolf JH (2003) Low breastfeeding rates and public health in the United States. Am J Public Health 93(12):2000–2010

    Article  PubMed  Google Scholar 

  • World Health Organization (2007) Semicarbazide. Available via: http://www.who.int/foodsafety/chem/sem/en/index.html cited April 18 2007

  • Yuan H, Song J, Li X, Li N, Dai J (2006) Immunomodulation and antitumor activity of [kappa]-carrageenan oligosaccharides. Cancer Lett 243:228–234

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The author wishes to thank Dimitri Stancioff, retired senior scientist from FMC Biopolymer for review of the history of carrageenan production and use and certain regulatory matters prior to 1970.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Duika Burges Watson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Burges Watson, D. Public health and carrageenan regulation: a review and analysis. J Appl Phycol 20, 505–513 (2008). https://doi.org/10.1007/s10811-007-9252-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10811-007-9252-x

Keywords

Navigation